Navigation Links
National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
Date:12/22/2009

WASHINGTON, Dec. 22 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Otsuka America Pharmaceutical, Inc. has joined the health policy research organization as a member.

Otsuka America Pharmaceutical, Inc. (OAPI) is a fast-growing specialty healthcare company that commercializes Otsuka-discovered product opportunities in North America, with a strong focus on and commitment to neuroscience, oncologic, and hospital products. OAPI is dedicated to improving patients' health and the quality of human life. OAPI is part of the Otsuka Pharmaceutical Group, and was established in 1989 by Otsuka America, Inc. (OAI), which is wholly owned by Otsuka Pharmaceutical Co., Ltd. (OPC).

In joining NPC, OAPI President and Chief Executive Officer Mark Altmeyer said, "I'm impressed with NPC's focus and achievements in the areas of comparative effectiveness research and evidence-based medicine. These are important issues that could affect not only research and development, but more importantly, patient health care."

Mr. Altmeyer will serve on NPC's Board of Directors, which includes top executives from the leading research-based pharmaceutical companies, including Abbott Laboratories, Astra Zeneca LP, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals Inc., Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., Eisai Inc., Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc, sanofi-aventis, Takeda Pharmaceuticals North America, Inc., and Teva Neuroscience.

"We are pleased to welcome Mr. Altmeyer and Otsuka to NPC, and we look forward to their active participation on our Board and research committees. As a leader in neuroscience, oncology and hospital therapies, Otsuka brings additional, valuable perspectives and expertise to NPC's scientific analyses and education to inform the health care policy debate," said NPC President Dan Leonard.

About the National Pharmaceutical Council

NPC's overarching mission is to sponsor and conduct scientific analyses of the appropriate use of biopharmaceuticals and the clinical and economic value of innovation. The organization's strategic focus is on evidence-based medicine (EBM) for health care decision-making, to ensure that patients have access to high-quality care. NPC was established in 1953 and is supported by the nation's major research-based pharmaceutical companies. For more information, visit www.npcnow.org.

SOURCE National Pharmaceutical Council


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
2. International, Well-Known Scientific Experts Say That New GFT505 Data Unlikely to Have the Potential to Affect the Established Role of Generic Fenofibrate and Bezafibrate in Managing Atherogenic Dyslipidemia
3. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
4. SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System
5. Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]
6. CPG International Launches a New Generation of VYCOM
7. New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
8. SRI International Receives National Institutes of Health Grants to Develop Improved Tomographic Imaging Technology
9. National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees Choice New Product Awards
10. PRA International Hosts an Infectious Diseases Audio Conference
11. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):